The Patent Finder

Terms ending in 2033

Bayer Pharma Aktiengesellschaft

Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,481,672Bicyclically Substituted Uracils and the Use Thereof
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 9,926,305Novel Salts
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 9,949,977Bicyclically Substituted Uracils and the Use Thereof
In force
 · Medium confidence
Bayer Pharma AktiengesellschaftIn forceMedium confidence
US 9,949,978Bicyclically Substituted Uracils and the Use Thereof
In force
 · Medium confidence
Bayer Pharma AktiengesellschaftIn forceMedium confidence
US 10,300,062Bicyclically Substituted Uracils and the Use Thereof
In force
 · Low confidence
Bayer Pharma AktiengesellschaftIn forceLow confidence
US 10,040,866Nucleic Acids and Host Cells Expressing Antibodies Capable of Binding to the Coagulation Factor Xia and Uses Thereof
In force
 · Medium confidence
Bayer Pharma AktiengesellschaftIn forceMedium confidence
US 10,221,247Antibodies Capable of Binding to the Coagulation Factor Xia and Uses Thereof
In force
 · Medium confidence
Bayer Pharma AktiengesellschaftIn forceMedium confidence
US 11,046,783Antibodies Capable of Binding to the Coagulation Factor Xia and Uses Thereof
In force
 · Medium confidence
Bayer Pharma AktiengesellschaftIn forceMedium confidence
US 9,783,614Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and uses thereof
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 8,981,104Novel 5-Aminotetrahydroquinoline-2-Carboxylic Acids and Their Use
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
13 more term ends in 2033 · Pro
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23.
Upgrade to Pro
21 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited